Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Pediatric Blood & Cancer|August 1, 2020
Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemiaAmanda C Winters, Kelly W Maloney, Amy L Treece, et al.Pediatric Blood & Cancer|November 6, 2008
Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumorsAngela D Trobaugh-Lotrario, Gail E Tomlinson, Milton J Finegold, et al.Journal of Community Health|August 2, 2023
Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, OklahomaWhitney Essex, Jorge Mera, Ashley Comiford, et al.Pediatric Blood & Cancer|April 13, 2006
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastomaAndrew M Donson, Steven O Addo-Yobo, Michael H Handler, et al.The Lancet. Oncology|April 8, 2015
Accepting risk in the acceleration of drug development for rare cancersDavid Ashley, David Thomas, Lia Gore, et al.British Journal of Haematology|September 4, 2010
Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in developmentAlisa B Lee-Sherick, Rachel M A Linger, Lia Gore, et al.Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Physician Perception of Patient Medication Adherence in a Cohort of Medicare Advantage Plans in TexasAmanda Winters, Tara Esse, Archita Bhansali, et al.Pediatric Blood & Cancer|June 2, 2005
Cord blood transplant in childhood ALLKelly K Sawczyn, Ralph Quinones, Janet Malcolm, et al.Neuro-Oncology|March 6, 2013
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhoodKenneth J Cohen, Iris C Gibbs, Paul G Fisher, et al.Pediatric Blood & Cancer|June 18, 2009
PARP1 expression in pediatric central nervous system tumorsValerie N Barton, Andrew M Donson, B K Kleinschmidt-DeMasters, et al.Pageof 15